Guido Gini
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 23
- Genetics 10
- Chronic Lymphocytic Leukemia Research 9
- Co-authors
- Attilio OlivieriPietro LeoniFranco LocatelliR RaimondiMichele CimminielloNicola MordiniAndrea BacigalupoMarco Zecca
- Journals
- Blood (9 papers)Transplant International (2 papers)The Oncologist (2 papers)Biology of Blood and Marrow Transplantation (2 papers)Hematological Oncology (2 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Guido Gini
33 papers receiving 616 citations
Peers
Comparison fields: 5 of 54
- Hematology 184
- Pathology and Forensic Medicine 241
- Ophthalmology 115
- Genetics 93
- Oncology 210
Countries citing papers authored by Guido Gini
This map shows the geographic impact of Guido Gini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Gini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Gini more than expected).
Fields of papers citing papers by Guido Gini
This network shows the impact of papers produced by Guido Gini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Gini. The network helps show where Guido Gini may publish in the future.
Co-authors
The 25 scholars most cited alongside Guido Gini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 4 | |
| 4 | 2021 | 6 | |
| 5 | 2021 | 3 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 2 | |
| 8 | 2019 | 13 | |
| 9 | 2019 | 15 | |
| 10 | 2017 | 2 | |
| 11 | 2015 | 29 | |
| 12 | 2014 | 2 | |
| 13 | 2014 | 0 | |
| 14 | 2013 | 18 | |
| 15 | Imatinib Is Safe and Effective In Patients with Refractory Chronic Graft Versus Host Disease: Analysis of Two Consecutive Prospective GITMO Studies | 2010 | 2 |
| 16 | 2007 | 119 | |
| 17 | 2005 | 15 | |
| 18 | 2004 | 6 | |
| 19 | Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment. | 2002 | 67 |
| 20 | 2000 | 7 |
About Guido Gini
Guido Gini is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Hematology and Neurology, having authored 37 papers that have together received 629 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (23 papers), Viral-associated cancers and disorders (12 papers), Chronic Lymphocytic Leukemia Research (9 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), CAR-T cell therapy research (3 papers) and Esophageal Cancer Research and Treatment (3 papers). The work is most often cited by research in Hematology (184 citations), Pathology and Forensic Medicine (241 citations), Ophthalmology (115 citations), Genetics (93 citations) and Oncology (210 citations). Guido Gini has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Attilio Olivieri, Pietro Leoni, Franco Locatelli, R Raimondi, Michele Cimminiello, Nicola Mordini, Andrea Bacigalupo, Marco Zecca, Adriana Balduzzi and Armando Gabrielli. Their work appears in journals such as Blood, Transplant International, The Oncologist, Biology of Blood and Marrow Transplantation and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.